[Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease]
- PMID: 16787593
[Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease]
Abstract
Objective: Immunovasculitis is a pathologic process of Kawasaki disease (KD) in the early stage and it is more likely to result from abnormal immunoactivation. It is thus speculated that the serum levels of some cytokines have changed before immunovasculitis occurs, suggesting the cytokines may be useful markers for the early diagnosis of KD. In this study, we measured the serum levels of soluble interleukin-2 receptors (sIL-2R), interleukin-6(IL-6) and high-sensitive C-reactive protein (hs-CRP) in patients with KD to evaluate the significance of these cytokines in the early diagnosis of KD.
Methods: Serum levels of sIL-2R and IL-6 were measured by rapid one-step sandwich enzyme immunoassay and the serum hs-CRP level was measured by Dade Behring BN ProSpec in 32 KD patients before and after intravenous immunoglobulin (IVIG) therapy. Twenty healthy children were used as the controls.
Results: Before IVIG therapy serum levels of sIL-2R (9253.41 +/- 2568.38 pg/mL vs 2161.53 +/- 696.92 pg/mL; P < 0.05), IL-6 (57.19 +/- 45.78 ng/mL vs 7.04 +/- 1.69 ng/mL; P < 0.05) and hs-CRP (117.69 +/- 42.05 mg/L vs 1.15 +/- 0.54 mg/L; P < 0.05) in KD patients were significantly higher than those in healthy controls. After IVIG therapy in KD patients serum IL-6 levels returned to normal and sIL-2R and hs-CRP levels decreased significantly but remained significantly higher than controls (P < 0.05). There was a positive correlation between sIL-2R and hs-CRP levels (r=0.60, P < 0.01). IL-6 levels positively correlated with hs-CRP levels in KD patients before IVIG therapy (r=0.68, P < 0.01).
Conclusions: IL-2R, IL-6 and hs-CRP are activated in the development of KD, and they may be of important value in the early diagnosis of KD.
Similar articles
-
Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.Rocz Akad Med Bialymst. 2004;49:246-51. Rocz Akad Med Bialymst. 2004. PMID: 15631351
-
Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.Eur Cytokine Netw. 2000 Sep;11(3):443-51. Eur Cytokine Netw. 2000. PMID: 11022130
-
Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.Circulation. 2005 Jan 4;111(1):38-43. doi: 10.1161/01.CIR.0000151311.38708.29. Epub 2004 Dec 20. Circulation. 2005. PMID: 15611368
-
A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.Cancer. 2003 May 15;97(10):2440-52. doi: 10.1002/cncr.11072. Cancer. 2003. PMID: 12733143 Review.
-
[The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].Pol Merkur Lekarski. 2004 Feb;16(92):188-90. Pol Merkur Lekarski. 2004. PMID: 15176308 Review. Polish.
Cited by
-
Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.EMBO Mol Med. 2013 Feb;5(2):210-20. doi: 10.1002/emmm.201201494. Epub 2012 Dec 20. EMBO Mol Med. 2013. PMID: 23281308 Free PMC article.
-
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.Clin Exp Med. 2019 May;19(2):173-181. doi: 10.1007/s10238-018-00544-5. Epub 2019 Jan 8. Clin Exp Med. 2019. PMID: 30617865
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous